• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者恶性胸腔积液预后特征的多因素分析。

Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients.

作者信息

Dieterich M, Goodman S N, Rojas-Corona R R, Emralino A B, Jimenez-Joseph D, Sherman M E

机构信息

Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.

出版信息

Acta Cytol. 1994 Nov-Dec;38(6):945-52.

PMID:7992584
Abstract

To identify prognostic indicators in breast cancer patients with malignant pleural effusions, we analyzed the cytopathologic features of 57 fluids representing the first pathologic diagnosis of a distant metastasis in these women. The specimens were analyzed prior to reviewing the clinical records. The median survival of 55 patients who died of the disease was five months following the effusion diagnosis (range, 1-114). Univariate analysis identified three cytopathologic features that correlated with relatively prolonged survival: arrangement of tumor cells in spheroids, slight nuclear atypia and low mitotic rate. Women whose tumor cells formed spheroids survived a median of 24.5 months as compared to 4 months for women with all other architectural patterns (P = .004). Multivariate analysis revealed that slight nuclear atypia and low mitotic rate strongly correlated with spheroid formation. Since breast cancers that form spheroids in effusions portend a relatively favorable prognosis, we recommend that cytopathologists comment on this pattern when reporting on metastatic breast carcinoma in pleural fluids.

摘要

为了确定伴有恶性胸腔积液的乳腺癌患者的预后指标,我们分析了57份液体的细胞病理学特征,这些液体代表了这些女性首次被病理诊断为远处转移。在查阅临床记录之前,先对标本进行分析。55例死于该病的患者在胸腔积液诊断后的中位生存期为5个月(范围为1-114个月)。单因素分析确定了与生存期相对延长相关的三个细胞病理学特征:肿瘤细胞呈球样排列、轻度核异型性和低有丝分裂率。肿瘤细胞形成球样的女性中位生存期为24.5个月,而具有所有其他结构模式的女性为4个月(P = 0.004)。多因素分析显示,轻度核异型性和低有丝分裂率与球样形成密切相关。由于在胸腔积液中形成球样的乳腺癌预示着相对较好的预后,我们建议细胞病理学家在报告胸腔积液转移性乳腺癌时对这种模式进行描述。

相似文献

1
Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients.乳腺癌患者恶性胸腔积液预后特征的多因素分析。
Acta Cytol. 1994 Nov-Dec;38(6):945-52.
2
Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.转移性乳腺癌患者的生存:原发肿瘤预后标志物的重要性。
Cancer. 2003 Feb 1;97(3):545-53. doi: 10.1002/cncr.11083.
3
Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.转移性乳腺癌患者每周化疗十年经验:预后因素的多变量分析
Anticancer Drugs. 2006 Nov;17(10):1193-200. doi: 10.1097/01.cad.0000231485.17063.d3.
4
Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.淋巴结阴性浸润性乳腺癌有丝分裂活性指数和纤维化灶的多因素预后评估
Eur J Cancer. 2005 Sep;41(14):2093-101. doi: 10.1016/j.ejca.2005.03.038.
5
In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.在淋巴结阴性的浸润性乳腺癌中,特定的染色体畸变与高有丝分裂活性密切相关,并且比分级、肿瘤直径和雌激素受体更能准确预测预后。
J Pathol. 2003 Dec;201(4):555-61. doi: 10.1002/path.1475.
6
Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.新辅助化疗的临床和病理反应与局部晚期乳腺癌预后的关系
J Surg Oncol. 2002 May;80(1):4-11. doi: 10.1002/jso.10090.
7
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.伴有肝转移的转移性乳腺癌:500例女性患者的临床病理、治疗及预后特征的登记研究
Breast Cancer Res Treat. 2006 Jun;97(3):237-44. doi: 10.1007/s10549-005-9117-4. Epub 2005 Dec 2.
8
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.乳腺内淋巴结转移是乳腺癌患者预后不良的独立预测因素。
Cancer. 2004 Sep 15;101(6):1330-7. doi: 10.1002/cncr.20515.
9
Pleural effusion in breast cancer: influence upon clinical course and survival.
Chemioterapia. 1986 Feb;5(1):66-9.
10
[Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].[使用OK-432和培养的自体胸腔积液淋巴细胞对恶性胸腔积液乳腺癌患者进行胸腔内给药:14年期间84例患者的分析]
Gan To Kagaku Ryoho. 1999 Oct;26(12):1796-800.

引用本文的文献

1
Ezrin Is Associated with Disease Progression in Ovarian Carcinoma.埃兹蛋白与卵巢癌的疾病进展相关。
PLoS One. 2016 Sep 13;11(9):e0162502. doi: 10.1371/journal.pone.0162502. eCollection 2016.
2
Malignant pleural and pericardial effusions and meningeal infiltrates without other metastases in breast cancer: A case report.乳腺癌伴恶性胸腔和心包积液及脑膜浸润且无其他转移:一例报告
Mol Clin Oncol. 2016 May;4(5):855-858. doi: 10.3892/mco.2016.798. Epub 2016 Mar 2.
3
Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention.
Snail1 在 EMT 调控和癌症耐药中的核心作用:治疗干预的靶点。
J Exp Clin Cancer Res. 2014 Aug 2;33(1):62. doi: 10.1186/s13046-014-0062-0.
4
Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids.Ezrin 和 BCAR1/p130Cas 作为 3-D 球体介导乳腺癌生长。
Clin Exp Metastasis. 2012 Aug;29(6):527-40. doi: 10.1007/s10585-012-9468-2. Epub 2012 Apr 4.
5
Breast carcinoma cells in primary tumors and effusions have different gene array profiles.原发肿瘤和胸水中的乳腺癌细胞具有不同的基因阵列谱。
J Oncol. 2010;2010:969084. doi: 10.1155/2010/969084. Epub 2009 Aug 11.
6
Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities.赖氨酰氧化酶样4在累及浆膜腔的肿瘤中以解剖部位特异性方式进行可变剪接。
Virchows Arch. 2009 Jan;454(1):71-9. doi: 10.1007/s00428-008-0694-6. Epub 2008 Nov 18.
7
Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions.染色质重塑因子Rsf-1在乳腺癌积液中的表达下调。
Hum Pathol. 2008 Apr;39(4):616-22. doi: 10.1016/j.humpath.2007.09.008. Epub 2008 Mar 4.
8
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.HLA - G在恶性间皮瘤和临床侵袭性乳腺癌中的表达。
Virchows Arch. 2006 Jul;449(1):31-9. doi: 10.1007/s00428-005-0144-7. Epub 2006 Mar 16.
9
The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.PEA3转录因子在卵巢癌和乳腺癌胸腔积液中的临床作用。
Clin Exp Metastasis. 2004;21(3):191-9. doi: 10.1023/b:clin.0000037703.37275.35.